Healthcare

4DMedical is a respiratory and lung-imaging technology company built around its patented XV Technology, which is designed to extract quantitative information about how the lungs function from medical imaging. Rather than relying solely on structural images, the platform aims to measure regional airflow and …

Cynata Therapeutics Limited (ASX:CYP), listed on the Australian Securities Exchange under the ticker CYP, announced on 19 June 2026 that it has received top-line results from the University of Sydney's Phase 3 SCUlpTOR trial evaluating CYP-004 in patients with osteoarthritis of the knee. The …

Vitrafy Life Sciences Limited (ASX:VFY) shares traded higher during the morning session on 19 June 2026 after the company opened its Share Purchase Plan for eligible shareholders. The stock rose 1.45% to AUD 2.80, adding AUD 0.040 on the day, while remaining up 112.12% …

CONNEQT Health Ltd (ASX:CQT) has secured firm commitments to raise approximately A$5.5 million through a two-tranche placement, providing additional funding to support commercial growth initiatives, product development and expansion of its connected health platform.

CONNEQT Health Ltd (ASX:CQT) has secured firm commitments to raise approximately A$5.5 million through a two-tranche placement, providing additional funding to support commercial growth initiatives, product development and expansion of its connected health platform.

Vitrafy Life Sciences Limited (ASX:VFY) shares traded higher during the morning session on 19 June 2026 after the company opened its Share Purchase Plan for eligible shareholders. The stock rose 1.45% to AUD 2.80, adding AUD 0.040 on the day, while remaining up 112.12% …

Cynata Therapeutics Limited (ASX:CYP), listed on the Australian Securities Exchange under the ticker CYP, announced on 19 June 2026 that it has received top-line results from the University of Sydney's Phase 3 SCUlpTOR trial evaluating CYP-004 in patients with osteoarthritis of the knee. The …